Sprint Bioscience AB (SPRINT) — Cash Flow Reinvestment Rate
Sprint Bioscience AB (SPRINT) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting Skr105.00K (capex Skr65.00K plus investments Skr40.00K) from operating cash flow of Skr115.84 Million. See free cash flow generation of Sprint Bioscience AB to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sprint Bioscience AB Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Sprint Bioscience AB across 4 annual periods. For the full cash flow conversion analysis, see how efficiently does Sprint Bioscience AB generate cash.
Annual Cash Flow Reinvestment Rate for Sprint Bioscience AB (2015–2025)
Year-by-year capital reinvestment analysis for Sprint Bioscience AB. See SPRINT FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr134.00K | Skr83.53 Million | Skr94.00K | ▼ -99.3% |
| 2023 | 0.21x | Skr4.91 Million | Skr22.87 Million | Skr2.45 Million | ▼ -91.4% |
| 2016 | 2.50x | Skr19.82 Million | Skr7.93 Million | Skr9.91 Million | ▼ -66.4% |
| 2015 | 7.43x | Skr6.19 Million | Skr833.54K | Skr6.19 Million | — |